3KIM M J,PARK Q,MIN H K,et al. Residual risk of transfusion-transmitted infection with human immuno- deficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010[J]. BMC Infect Dis, 2012,12:160--162.
4KAFI-ABAD S A, REZVAN H, ABOLGHASEMI H, et al. Prevalence and trends of human immunodefieien- cy virus, hepatitis B virus,and hepatitis C virus among blood donors in Iran, 2004 through 2007[J]. Transfu- sion, 2009,49:2214--2220.
5LIU Y, LI P, LI C, et al. Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China [J]. Virol J ,2010,19 : 193-- 195.
6LELIE N,HEATON A. Hepatitis B - a review of the role of NAT in enhancing blood safety[J]. J Clin Vir- ol,2006,36:S1--2.
